Maxigen Biotech Inc.(TW:1783)
NT$36.00+0.75 (+2.13%)
TW:1783
Maxigen Biotech Inc. Revenue
NT$36.00
At close:+0.75 (+2.13%)
Maxigen Biotech Inc. (1783) Revenue
Maxigen Biotech Inc. Revenue
Maxigen Biotech Inc. had a revenue of 221.01M in the quarter ending Jun 30, 2026, with 15.79%. This bring the company's revenue in the last twelve months to 837.44M, Increased 1.48%. In the fiscal year ending Dec 31, 2025, Maxigen Biotech Inc. had annual revenue of 811.56M with 19.23% growth.
- Revenue (ttm)
- 837.44M
- Revenue Growth
- 8.14%
- P/S Ratio
- 3.90
- Revenue/Employee
- TWD 6,390,268
- Employees
- 127
- Market Cap
- TWD 3.16B
Revenue Chart
Maxigen Biotech Inc. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 811.56M | 130.91M | 19.23% |
| Dec 31, 2024 | 680.65M | 58.54M | 9.41% |
| Dec 31, 2023 | 622.12M | 17.68M | 2.93% |
| Dec 31, 2022 | 604.43M | 92.45M | 18.06% |
| Dec 31, 2021 | 511.98M | 54.28M | 11.86% |
| Dec 31, 2020 | 457.69M | 5.49M | 1.21% |
| Dec 31, 2019 | 452.20M | 24.52M | 5.73% |
| Dec 31, 2018 | 427.68M | 119.00K | 0.03% |
| Dec 31, 2017 | 427.56M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.